Global Pharma Hard Capsules Market Growth 2024-2030
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pharma Hard Capsules Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Pharma Hard Capsules by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Pharma Hard Capsules by Country/Region, 2019, 2023 & 2030 2.2 Pharma Hard Capsules Segment by Type 2.2.1 Stomach-soluble Gelatin Capsules 2.2.2 Enterosoluble Vacant Gelatin Capsules 2.2.3 Other 2.3 Pharma Hard Capsules Sales by Type 2.3.1 Global Pharma Hard Capsules Sales Market Share by Type (2019-2024) 2.3.2 Global Pharma Hard Capsules Revenue and Market Share by Type (2019-2024) 2.3.3 Global Pharma Hard Capsules Sale Price by Type (2019-2024) 2.4 Pharma Hard Capsules Segment by Application 2.4.1 Pharmaceutical 2.4.2 Healthcare Products 2.4.3 Other 2.5 Pharma Hard Capsules Sales by Application 2.5.1 Global Pharma Hard Capsules Sale Market Share by Application (2019-2024) 2.5.2 Global Pharma Hard Capsules Revenue and Market Share by Application (2019-2024) 2.5.3 Global Pharma Hard Capsules Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Pharma Hard Capsules Breakdown Data by Company 3.1.1 Global Pharma Hard Capsules Annual Sales by Company (2019-2024) 3.1.2 Global Pharma Hard Capsules Sales Market Share by Company (2019-2024) 3.2 Global Pharma Hard Capsules Annual Revenue by Company (2019-2024) 3.2.1 Global Pharma Hard Capsules Revenue by Company (2019-2024) 3.2.2 Global Pharma Hard Capsules Revenue Market Share by Company (2019-2024) 3.3 Global Pharma Hard Capsules Sale Price by Company 3.4 Key Manufacturers Pharma Hard Capsules Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pharma Hard Capsules Product Location Distribution 3.4.2 Players Pharma Hard Capsules Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Pharma Hard Capsules by Geographic Region 4.1 World Historic Pharma Hard Capsules Market Size by Geographic Region (2019-2024) 4.1.1 Global Pharma Hard Capsules Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Pharma Hard Capsules Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Pharma Hard Capsules Market Size by Country/Region (2019-2024) 4.2.1 Global Pharma Hard Capsules Annual Sales by Country/Region (2019-2024) 4.2.2 Global Pharma Hard Capsules Annual Revenue by Country/Region (2019-2024) 4.3 Americas Pharma Hard Capsules Sales Growth 4.4 APAC Pharma Hard Capsules Sales Growth 4.5 Europe Pharma Hard Capsules Sales Growth 4.6 Middle East & Africa Pharma Hard Capsules Sales Growth 5 Americas 5.1 Americas Pharma Hard Capsules Sales by Country 5.1.1 Americas Pharma Hard Capsules Sales by Country (2019-2024) 5.1.2 Americas Pharma Hard Capsules Revenue by Country (2019-2024) 5.2 Americas Pharma Hard Capsules Sales by Type (2019-2024) 5.3 Americas Pharma Hard Capsules Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pharma Hard Capsules Sales by Region 6.1.1 APAC Pharma Hard Capsules Sales by Region (2019-2024) 6.1.2 APAC Pharma Hard Capsules Revenue by Region (2019-2024) 6.2 APAC Pharma Hard Capsules Sales by Type (2019-2024) 6.3 APAC Pharma Hard Capsules Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Pharma Hard Capsules by Country 7.1.1 Europe Pharma Hard Capsules Sales by Country (2019-2024) 7.1.2 Europe Pharma Hard Capsules Revenue by Country (2019-2024) 7.2 Europe Pharma Hard Capsules Sales by Type (2019-2024) 7.3 Europe Pharma Hard Capsules Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pharma Hard Capsules by Country 8.1.1 Middle East & Africa Pharma Hard Capsules Sales by Country (2019-2024) 8.1.2 Middle East & Africa Pharma Hard Capsules Revenue by Country (2019-2024) 8.2 Middle East & Africa Pharma Hard Capsules Sales by Type (2019-2024) 8.3 Middle East & Africa Pharma Hard Capsules Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Pharma Hard Capsules 10.3 Manufacturing Process Analysis of Pharma Hard Capsules 10.4 Industry Chain Structure of Pharma Hard Capsules 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Pharma Hard Capsules Distributors 11.3 Pharma Hard Capsules Customer 12 World Forecast Review for Pharma Hard Capsules by Geographic Region 12.1 Global Pharma Hard Capsules Market Size Forecast by Region 12.1.1 Global Pharma Hard Capsules Forecast by Region (2025-2030) 12.1.2 Global Pharma Hard Capsules Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Pharma Hard Capsules Forecast by Type (2025-2030) 12.7 Global Pharma Hard Capsules Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Lonza 13.1.1 Lonza Company Information 13.1.2 Lonza Pharma Hard Capsules Product Portfolios and Specifications 13.1.3 Lonza Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Lonza Main Business Overview 13.1.5 Lonza Latest Developments 13.2 Qualicaps 13.2.1 Qualicaps Company Information 13.2.2 Qualicaps Pharma Hard Capsules Product Portfolios and Specifications 13.2.3 Qualicaps Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 Qualicaps Main Business Overview 13.2.5 Qualicaps Latest Developments 13.3 ACG 13.3.1 ACG Company Information 13.3.2 ACG Pharma Hard Capsules Product Portfolios and Specifications 13.3.3 ACG Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 ACG Main Business Overview 13.3.5 ACG Latest Developments 13.4 Suheung 13.4.1 Suheung Company Information 13.4.2 Suheung Pharma Hard Capsules Product Portfolios and Specifications 13.4.3 Suheung Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Suheung Main Business Overview 13.4.5 Suheung Latest Developments 13.5 Farmacapsulas SA 13.5.1 Farmacapsulas SA Company Information 13.5.2 Farmacapsulas SA Pharma Hard Capsules Product Portfolios and Specifications 13.5.3 Farmacapsulas SA Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Farmacapsulas SA Main Business Overview 13.5.5 Farmacapsulas SA Latest Developments 13.6 ERAWAT PHARMA LIMITED 13.6.1 ERAWAT PHARMA LIMITED Company Information 13.6.2 ERAWAT PHARMA LIMITED Pharma Hard Capsules Product Portfolios and Specifications 13.6.3 ERAWAT PHARMA LIMITED Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 ERAWAT PHARMA LIMITED Main Business Overview 13.6.5 ERAWAT PHARMA LIMITED Latest Developments 13.7 Dah Feng Capsule 13.7.1 Dah Feng Capsule Company Information 13.7.2 Dah Feng Capsule Pharma Hard Capsules Product Portfolios and Specifications 13.7.3 Dah Feng Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.7.4 Dah Feng Capsule Main Business Overview 13.7.5 Dah Feng Capsule Latest Developments 13.8 Lefan Capsule 13.8.1 Lefan Capsule Company Information 13.8.2 Lefan Capsule Pharma Hard Capsules Product Portfolios and Specifications 13.8.3 Lefan Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.8.4 Lefan Capsule Main Business Overview 13.8.5 Lefan Capsule Latest Developments 13.9 Shing Lih Fang 13.9.1 Shing Lih Fang Company Information 13.9.2 Shing Lih Fang Pharma Hard Capsules Product Portfolios and Specifications 13.9.3 Shing Lih Fang Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.9.4 Shing Lih Fang Main Business Overview 13.9.5 Shing Lih Fang Latest Developments 13.10 Roxlor 13.10.1 Roxlor Company Information 13.10.2 Roxlor Pharma Hard Capsules Product Portfolios and Specifications 13.10.3 Roxlor Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.10.4 Roxlor Main Business Overview 13.10.5 Roxlor Latest Developments 13.11 Nectar Lifesciences 13.11.1 Nectar Lifesciences Company Information 13.11.2 Nectar Lifesciences Pharma Hard Capsules Product Portfolios and Specifications 13.11.3 Nectar Lifesciences Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.11.4 Nectar Lifesciences Main Business Overview 13.11.5 Nectar Lifesciences Latest Developments 13.12 Kangke 13.12.1 Kangke Company Information 13.12.2 Kangke Pharma Hard Capsules Product Portfolios and Specifications 13.12.3 Kangke Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.12.4 Kangke Main Business Overview 13.12.5 Kangke Latest Developments 13.13 Angtai 13.13.1 Angtai Company Information 13.13.2 Angtai Pharma Hard Capsules Product Portfolios and Specifications 13.13.3 Angtai Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.13.4 Angtai Main Business Overview 13.13.5 Angtai Latest Developments 13.14 Tsingtao Capsule 13.14.1 Tsingtao Capsule Company Information 13.14.2 Tsingtao Capsule Pharma Hard Capsules Product Portfolios and Specifications 13.14.3 Tsingtao Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.14.4 Tsingtao Capsule Main Business Overview 13.14.5 Tsingtao Capsule Latest Developments 13.15 Huangshan Capsule 13.15.1 Huangshan Capsule Company Information 13.15.2 Huangshan Capsule Pharma Hard Capsules Product Portfolios and Specifications 13.15.3 Huangshan Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.15.4 Huangshan Capsule Main Business Overview 13.15.5 Huangshan Capsule Latest Developments 13.16 MEIHUA Group 13.16.1 MEIHUA Group Company Information 13.16.2 MEIHUA Group Pharma Hard Capsules Product Portfolios and Specifications 13.16.3 MEIHUA Group Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.16.4 MEIHUA Group Main Business Overview 13.16.5 MEIHUA Group Latest Developments 13.17 Yili Capsule 13.17.1 Yili Capsule Company Information 13.17.2 Yili Capsule Pharma Hard Capsules Product Portfolios and Specifications 13.17.3 Yili Capsule Pharma Hard Capsules Sales, Revenue, Price and Gross Margin (2019-2024) 13.17.4 Yili Capsule Main Business Overview 13.17.5 Yili Capsule Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Pharma Hard Capsules Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions) Table 2. Pharma Hard Capsules Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Stomach-soluble Gelatin Capsules Table 4. Major Players of Enterosoluble Vacant Gelatin Capsules Table 5. Major Players of Other Table 6. Global Pharma Hard Capsules Sales by Type (2019-2024) & (K Units) Table 7. Global Pharma Hard Capsules Sales Market Share by Type (2019-2024) Table 8. Global Pharma Hard Capsules Revenue by Type (2019-2024) & ($ million) Table 9. Global Pharma Hard Capsules Revenue Market Share by Type (2019-2024) Table 10. Global Pharma Hard Capsules Sale Price by Type (2019-2024) & (US$/Unit) Table 11. Global Pharma Hard Capsules Sale by Application (2019-2024) & (K Units) Table 12. Global Pharma Hard Capsules Sale Market Share by Application (2019-2024) Table 13. Global Pharma Hard Capsules Revenue by Application (2019-2024) & ($ million) Table 14. Global Pharma Hard Capsules Revenue Market Share by Application (2019-2024) Table 15. Global Pharma Hard Capsules Sale Price by Application (2019-2024) & (US$/Unit) Table 16. Global Pharma Hard Capsules Sales by Company (2019-2024) & (K Units) Table 17. Global Pharma Hard Capsules Sales Market Share by Company (2019-2024) Table 18. Global Pharma Hard Capsules Revenue by Company (2019-2024) & ($ millions) Table 19. Global Pharma Hard Capsules Revenue Market Share by Company (2019-2024) Table 20. Global Pharma Hard Capsules Sale Price by Company (2019-2024) & (US$/Unit) Table 21. Key Manufacturers Pharma Hard Capsules Producing Area Distribution and Sales Area Table 22. Players Pharma Hard Capsules Products Offered Table 23. Pharma Hard Capsules Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Pharma Hard Capsules Sales by Geographic Region (2019-2024) & (K Units) Table 27. Global Pharma Hard Capsules Sales Market Share Geographic Region (2019-2024) Table 28. Global Pharma Hard Capsules Revenue by Geographic Region (2019-2024) & ($ millions) Table 29. Global Pharma Hard Capsules Revenue Market Share by Geographic Region (2019-2024) Table 30. Global Pharma Hard Capsules Sales by Country/Region (2019-2024) & (K Units) Table 31. Global Pharma Hard Capsules Sales Market Share by Country/Region (2019-2024) Table 32. Global Pharma Hard Capsules Revenue by Country/Region (2019-2024) & ($ millions) Table 33. Global Pharma Hard Capsules Revenue Market Share by Country/Region (2019-2024) Table 34. Americas Pharma Hard Capsules Sales by Country (2019-2024) & (K Units) Table 35. Americas Pharma Hard Capsules Sales Market Share by Country (2019-2024) Table 36. Americas Pharma Hard Capsules Revenue by Country (2019-2024) & ($ millions) Table 37. Americas Pharma Hard Capsules Sales by Type (2019-2024) & (K Units) Table 38. Americas Pharma Hard Capsules Sales by Application (2019-2024) & (K Units) Table 39. APAC Pharma Hard Capsules Sales by Region (2019-2024) & (K Units) Table 40. APAC Pharma Hard Capsules Sales Market Share by Region (2019-2024) Table 41. APAC Pharma Hard Capsules Revenue by Region (2019-2024) & ($ millions) Table 42. APAC Pharma Hard Capsules Sales by Type (2019-2024) & (K Units) Table 43. APAC Pharma Hard Capsules Sales by Application (2019-2024) & (K Units) Table 44. Europe Pharma Hard Capsules Sales by Country (2019-2024) & (K Units) Table 45. Europe Pharma Hard Capsules Revenue by Country (2019-2024) & ($ millions) Table 46. Europe Pharma Hard Capsules Sales by Type (2019-2024) & (K Units) Table 47. Europe Pharma Hard Capsules Sales by Application (2019-2024) & (K Units) Table 48. Middle East & Africa Pharma Hard Capsules Sales by Country (2019-2024) & (K Units) Table 49. Middle East & Africa Pharma Hard Capsules Revenue Market Share by Country (2019-2024) Table 50. Middle East & Africa Pharma Hard Capsules Sales by Type (2019-2024) & (K Units) Table 51. Middle East & Africa Pharma Hard Capsules Sales by Application (2019-2024) & (K Units) Table 52. Key Market Drivers & Growth Opportunities of Pharma Hard Capsules Table 53. Key Market Challenges & Risks of Pharma Hard Capsules Table 54. Key Industry Trends of Pharma Hard Capsules Table 55. Pharma Hard Capsules Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Pharma Hard Capsules Distributors List Table 58. Pharma Hard Capsules Customer List Table 59. Global Pharma Hard Capsules Sales Forecast by Region (2025-2030) & (K Units) Table 60. Global Pharma Hard Capsules Revenue Forecast by Region (2025-2030) & ($ millions) Table 61. Americas Pharma Hard Capsules Sales Forecast by Country (2025-2030) & (K Units) Table 62. Americas Pharma Hard Capsules Annual Revenue Forecast by Country (2025-2030) & ($ millions) Table 63. APAC Pharma Hard Capsules Sales Forecast by Region (2025-2030) & (K Units) Table 64. APAC Pharma Hard Capsules Annual Revenue Forecast by Region (2025-2030) & ($ millions) Table 65. Europe Pharma Hard Capsules Sales Forecast by Country (2025-2030) & (K Units) Table 66. Europe Pharma Hard Capsules Revenue Forecast by Country (2025-2030) & ($ millions) Table 67. Middle East & Africa Pharma Hard Capsules Sales Forecast by Country (2025-2030) & (K Units) Table 68. Middle East & Africa Pharma Hard Capsules Revenue Forecast by Country (2025-2030) & ($ millions) Table 69. Global Pharma Hard Capsules Sales Forecast by Type (2025-2030) & (K Units) Table 70. Global Pharma Hard Capsules Revenue Forecast by Type (2025-2030) & ($ millions) Table 71. Global Pharma Hard Capsules Sales Forecast by Application (2025-2030) & (K Units) Table 72. Global Pharma Hard Capsules Revenue Forecast by Application (2025-2030) & ($ millions) Table 73. Lonza Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 74. Lonza Pharma Hard Capsules Product Portfolios and Specifications Table 75. Lonza Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 76. Lonza Main Business Table 77. Lonza Latest Developments Table 78. Qualicaps Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 79. Qualicaps Pharma Hard Capsules Product Portfolios and Specifications Table 80. Qualicaps Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 81. Qualicaps Main Business Table 82. Qualicaps Latest Developments Table 83. ACG Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 84. ACG Pharma Hard Capsules Product Portfolios and Specifications Table 85. ACG Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 86. ACG Main Business Table 87. ACG Latest Developments Table 88. Suheung Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 89. Suheung Pharma Hard Capsules Product Portfolios and Specifications Table 90. Suheung Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 91. Suheung Main Business Table 92. Suheung Latest Developments Table 93. Farmacapsulas SA Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 94. Farmacapsulas SA Pharma Hard Capsules Product Portfolios and Specifications Table 95. Farmacapsulas SA Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 96. Farmacapsulas SA Main Business Table 97. Farmacapsulas SA Latest Developments Table 98. ERAWAT PHARMA LIMITED Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 99. ERAWAT PHARMA LIMITED Pharma Hard Capsules Product Portfolios and Specifications Table 100. ERAWAT PHARMA LIMITED Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 101. ERAWAT PHARMA LIMITED Main Business Table 102. ERAWAT PHARMA LIMITED Latest Developments Table 103. Dah Feng Capsule Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 104. Dah Feng Capsule Pharma Hard Capsules Product Portfolios and Specifications Table 105. Dah Feng Capsule Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 106. Dah Feng Capsule Main Business Table 107. Dah Feng Capsule Latest Developments Table 108. Lefan Capsule Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 109. Lefan Capsule Pharma Hard Capsules Product Portfolios and Specifications Table 110. Lefan Capsule Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 111. Lefan Capsule Main Business Table 112. Lefan Capsule Latest Developments Table 113. Shing Lih Fang Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 114. Shing Lih Fang Pharma Hard Capsules Product Portfolios and Specifications Table 115. Shing Lih Fang Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 116. Shing Lih Fang Main Business Table 117. Shing Lih Fang Latest Developments Table 118. Roxlor Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 119. Roxlor Pharma Hard Capsules Product Portfolios and Specifications Table 120. Roxlor Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 121. Roxlor Main Business Table 122. Roxlor Latest Developments Table 123. Nectar Lifesciences Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 124. Nectar Lifesciences Pharma Hard Capsules Product Portfolios and Specifications Table 125. Nectar Lifesciences Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 126. Nectar Lifesciences Main Business Table 127. Nectar Lifesciences Latest Developments Table 128. Kangke Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 129. Kangke Pharma Hard Capsules Product Portfolios and Specifications Table 130. Kangke Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 131. Kangke Main Business Table 132. Kangke Latest Developments Table 133. Angtai Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 134. Angtai Pharma Hard Capsules Product Portfolios and Specifications Table 135. Angtai Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 136. Angtai Main Business Table 137. Angtai Latest Developments Table 138. Tsingtao Capsule Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 139. Tsingtao Capsule Pharma Hard Capsules Product Portfolios and Specifications Table 140. Tsingtao Capsule Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 141. Tsingtao Capsule Main Business Table 142. Tsingtao Capsule Latest Developments Table 143. Huangshan Capsule Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 144. Huangshan Capsule Pharma Hard Capsules Product Portfolios and Specifications Table 145. Huangshan Capsule Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 146. Huangshan Capsule Main Business Table 147. Huangshan Capsule Latest Developments Table 148. MEIHUA Group Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 149. MEIHUA Group Pharma Hard Capsules Product Portfolios and Specifications Table 150. MEIHUA Group Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 151. MEIHUA Group Main Business Table 152. MEIHUA Group Latest Developments Table 153. Yili Capsule Basic Information, Pharma Hard Capsules Manufacturing Base, Sales Area and Its Competitors Table 154. Yili Capsule Pharma Hard Capsules Product Portfolios and Specifications Table 155. Yili Capsule Pharma Hard Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024) Table 156. Yili Capsule Main Business Table 157. Yili Capsule Latest Developments List of Figures Figure 1. Picture of Pharma Hard Capsules Figure 2. Pharma Hard Capsules Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pharma Hard Capsules Sales Growth Rate 2019-2030 (K Units) Figure 7. Global Pharma Hard Capsules Revenue Growth Rate 2019-2030 ($ millions) Figure 8. Pharma Hard Capsules Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 9. Pharma Hard Capsules Sales Market Share by Country/Region (2023) Figure 10. Pharma Hard Capsules Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 11. Product Picture of Stomach-soluble Gelatin Capsules Figure 12. Product Picture of Enterosoluble Vacant Gelatin Capsules Figure 13. Product Picture of Other Figure 14. Global Pharma Hard Capsules Sales Market Share by Type in 2023 Figure 15. Global Pharma Hard Capsules Revenue Market Share by Type (2019-2024) Figure 16. Pharma Hard Capsules Consumed in Pharmaceutical Figure 17. Global Pharma Hard Capsules Market: Pharmaceutical (2019-2024) & (K Units) Figure 18. Pharma Hard Capsules Consumed in Healthcare Products Figure 19. Global Pharma Hard Capsules Market: Healthcare Products (2019-2024) & (K Units) Figure 20. Pharma Hard Capsules Consumed in Other Figure 21. Global Pharma Hard Capsules Market: Other (2019-2024) & (K Units) Figure 22. Global Pharma Hard Capsules Sale Market Share by Application (2023) Figure 23. Global Pharma Hard Capsules Revenue Market Share by Application in 2023 Figure 24. Pharma Hard Capsules Sales by Company in 2023 (K Units) Figure 25. Global Pharma Hard Capsules Sales Market Share by Company in 2023 Figure 26. Pharma Hard Capsules Revenue by Company in 2023 ($ millions) Figure 27. Global Pharma Hard Capsules Revenue Market Share by Company in 2023 Figure 28. Global Pharma Hard Capsules Sales Market Share by Geographic Region (2019-2024) Figure 29. Global Pharma Hard Capsules Revenue Market Share by Geographic Region in 2023 Figure 30. Americas Pharma Hard Capsules Sales 2019-2024 (K Units) Figure 31. Americas Pharma Hard Capsules Revenue 2019-2024 ($ millions) Figure 32. APAC Pharma Hard Capsules Sales 2019-2024 (K Units) Figure 33. APAC Pharma Hard Capsules Revenue 2019-2024 ($ millions) Figure 34. Europe Pharma Hard Capsules Sales 2019-2024 (K Units) Figure 35. Europe Pharma Hard Capsules Revenue 2019-2024 ($ millions) Figure 36. Middle East & Africa Pharma Hard Capsules Sales 2019-2024 (K Units) Figure 37. Middle East & Africa Pharma Hard Capsules Revenue 2019-2024 ($ millions) Figure 38. Americas Pharma Hard Capsules Sales Market Share by Country in 2023 Figure 39. Americas Pharma Hard Capsules Revenue Market Share by Country (2019-2024) Figure 40. Americas Pharma Hard Capsules Sales Market Share by Type (2019-2024) Figure 41. Americas Pharma Hard Capsules Sales Market Share by Application (2019-2024) Figure 42. United States Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 43. Canada Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 44. Mexico Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 45. Brazil Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 46. APAC Pharma Hard Capsules Sales Market Share by Region in 2023 Figure 47. APAC Pharma Hard Capsules Revenue Market Share by Region (2019-2024) Figure 48. APAC Pharma Hard Capsules Sales Market Share by Type (2019-2024) Figure 49. APAC Pharma Hard Capsules Sales Market Share by Application (2019-2024) Figure 50. China Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 51. Japan Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 52. South Korea Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 53. Southeast Asia Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 54. India Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 55. Australia Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 56. China Taiwan Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 57. Europe Pharma Hard Capsules Sales Market Share by Country in 2023 Figure 58. Europe Pharma Hard Capsules Revenue Market Share by Country (2019-2024) Figure 59. Europe Pharma Hard Capsules Sales Market Share by Type (2019-2024) Figure 60. Europe Pharma Hard Capsules Sales Market Share by Application (2019-2024) Figure 61. Germany Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 62. France Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 63. UK Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 64. Italy Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 65. Russia Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 66. Middle East & Africa Pharma Hard Capsules Sales Market Share by Country (2019-2024) Figure 67. Middle East & Africa Pharma Hard Capsules Sales Market Share by Type (2019-2024) Figure 68. Middle East & Africa Pharma Hard Capsules Sales Market Share by Application (2019-2024) Figure 69. Egypt Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 70. South Africa Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 71. Israel Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 72. Turkey Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 73. GCC Countries Pharma Hard Capsules Revenue Growth 2019-2024 ($ millions) Figure 74. Manufacturing Cost Structure Analysis of Pharma Hard Capsules in 2023 Figure 75. Manufacturing Process Analysis of Pharma Hard Capsules Figure 76. Industry Chain Structure of Pharma Hard Capsules Figure 77. Channels of Distribution Figure 78. Global Pharma Hard Capsules Sales Market Forecast by Region (2025-2030) Figure 79. Global Pharma Hard Capsules Revenue Market Share Forecast by Region (2025-2030) Figure 80. Global Pharma Hard Capsules Sales Market Share Forecast by Type (2025-2030) Figure 81. Global Pharma Hard Capsules Revenue Market Share Forecast by Type (2025-2030) Figure 82. Global Pharma Hard Capsules Sales Market Share Forecast by Application (2025-2030) Figure 83. Global Pharma Hard Capsules Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza|||Qualicaps|||ACG|||Suheung|||Farmacapsulas SA|||ERAWAT PHARMA LIMITED|||Dah Feng Capsule|||Lefan Capsule|||Shing Lih Fang|||Roxlor|||Nectar Lifesciences|||Kangke|||Angtai|||Tsingtao Capsule|||Huangshan Capsule|||MEIHUA Group|||Yili Capsule